Case Report

Fatal Colitis in a Hemophilic Patient With Inhibitor

Authors: KENNETH A. SCHWARTZ MD, JOHN A. PENNER MD, ROBERT F. FEKETY JR. MD, ROBERT W. BAILEY MD.

Abstract

PSEUDOMEMBRANOUS ENTEROCOLITIS is a recognized complication resulting from the use of diverse kinds of antibiotics. Recent reports have noted this development following the use of lincomycin and a related antibiotic, clindamycin.1–4 The following report describes a fatal case of colitis associated with an antibiotic program which included clindamycin. Our patient with mild classical hemophilia developed a high level factor VIII inhibitor after major surgery and was successfully managed with a plasma concentrate, activated prothrombin complex (Auto IX*).5 Subsequently he deyeloped an antibiotic-associated hemorrhagic ulcerative colitis. The combination of a severe hemorrhagic colitis coupled with a factor VIII inhibitor proved to be lethal.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References